Menu
GeneBe

rs200091822

Variant summary

Our verdict is Benign. Variant got -7 ACMG points: 0P and 7B. BP4_ModerateBP6BS2

The NM_000352.6(ABCC8):c.-8G>T variant causes a 5 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00437 in 1,545,004 control chromosomes in the GnomAD database, including 23 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: 𝑓 0.0026 ( 1 hom., cov: 33)
Exomes 𝑓: 0.0046 ( 22 hom. )

Consequence

ABCC8
NM_000352.6 5_prime_UTR

Scores

2

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:3B:5

Conservation

PhyloP100: 1.65
Variant links:
Genes affected
ABCC8 (HGNC:59): (ATP binding cassette subfamily C member 8) The protein encoded by this gene is a member of the superfamily of ATP-binding cassette (ABC) transporters. ABC proteins transport various molecules across extra- and intra-cellular membranes. ABC genes are divided into seven distinct subfamilies (ABC1, MDR/TAP, MRP, ALD, OABP, GCN20, White). This protein is a member of the MRP subfamily which is involved in multi-drug resistance. This protein functions as a modulator of ATP-sensitive potassium channels and insulin release. Mutations in the ABCC8 gene and deficiencies in the encoded protein have been observed in patients with hyperinsulinemic hypoglycemia of infancy, an autosomal recessive disorder of unregulated and high insulin secretion. Mutations have also been associated with non-insulin-dependent diabetes mellitus type II, an autosomal dominant disease of defective insulin secretion. Alternatively spliced transcript variants have been found for this gene. [provided by RefSeq, Jul 2020]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -7 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.22).
BP6
Variant 11-17476784-C-A is Benign according to our data. Variant chr11-17476784-C-A is described in ClinVar as [Conflicting_classifications_of_pathogenicity]. Clinvar id is 255928.We mark this variant Likely_benign, oryginal submissions are: {Likely_benign=3, Uncertain_significance=3, Benign=2}.
BS2
High Homozygotes in GnomAdExome at 2 SD gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
ABCC8NM_000352.6 linkuse as main transcriptc.-8G>T 5_prime_UTR_variant 1/39 ENST00000389817.8
LOC124902641XR_007062609.1 linkuse as main transcriptn.81+53C>A intron_variant, non_coding_transcript_variant

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
ABCC8ENST00000389817.8 linkuse as main transcriptc.-8G>T 5_prime_UTR_variant 1/391 NM_000352.6 P4Q09428-1
ENST00000662030.1 linkuse as main transcriptn.137+53C>A intron_variant, non_coding_transcript_variant

Frequencies

GnomAD3 genomes
AF:
0.00264
AC:
402
AN:
152012
Hom.:
1
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.00118
Gnomad AMI
AF:
0.00219
Gnomad AMR
AF:
0.00223
Gnomad ASJ
AF:
0.000289
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000829
Gnomad FIN
AF:
0.000472
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00443
Gnomad OTH
AF:
0.00287
GnomAD3 exomes
AF:
0.00258
AC:
378
AN:
146580
Hom.:
2
AF XY:
0.00279
AC XY:
221
AN XY:
79290
show subpopulations
Gnomad AFR exome
AF:
0.00148
Gnomad AMR exome
AF:
0.00170
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.000776
Gnomad FIN exome
AF:
0.000445
Gnomad NFE exome
AF:
0.00508
Gnomad OTH exome
AF:
0.00298
GnomAD4 exome
AF:
0.00455
AC:
6341
AN:
1392884
Hom.:
22
Cov.:
31
AF XY:
0.00439
AC XY:
3019
AN XY:
687810
show subpopulations
Gnomad4 AFR exome
AF:
0.000702
Gnomad4 AMR exome
AF:
0.00178
Gnomad4 ASJ exome
AF:
0.000162
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.00100
Gnomad4 FIN exome
AF:
0.000721
Gnomad4 NFE exome
AF:
0.00548
Gnomad4 OTH exome
AF:
0.00406
GnomAD4 genome
AF:
0.00265
AC:
403
AN:
152120
Hom.:
1
Cov.:
33
AF XY:
0.00253
AC XY:
188
AN XY:
74344
show subpopulations
Gnomad4 AFR
AF:
0.00118
Gnomad4 AMR
AF:
0.00222
Gnomad4 ASJ
AF:
0.000289
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00104
Gnomad4 FIN
AF:
0.000472
Gnomad4 NFE
AF:
0.00443
Gnomad4 OTH
AF:
0.00284
Alfa
AF:
0.00323
Hom.:
0
Bravo
AF:
0.00267

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:3Benign:5
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

not specified Uncertain:1Benign:2
Uncertain significance, criteria provided, single submitterclinical testingGenetic Services Laboratory, University of ChicagoDec 11, 2015- -
Likely benign, criteria provided, single submitterclinical testingPreventionGenetics, part of Exact Sciences-- -
Benign, criteria provided, single submitterclinical testingWomen's Health and Genetics/Laboratory Corporation of America, LabCorpOct 12, 2021Variant summary: ABCC8 c.-8G>T alters a non-conserved nucleotide located in the untranslated mRNA region upstream of the initiation codon. The variant allele was found at a frequency of 0.0026 in 290940 control chromosomes, including 3 homozygotes (gnomAD v2.1 and gnomAD v3.1 datasets). The variant was found predominantly within the Non-Finnish European subpopulation at a frequency of 0.0046. The observed variant frequency within Non-Finnish European control individuals in the gnomAD database is approximately 1.4 fold of the estimated maximal expected allele frequency for a pathogenic variant in ABCC8 causing Familial Hyperinsulinism phenotype (0.0034), strongly suggesting that the variant is a benign polymorphism found primarily in populations of Non-Finnish European origin. c.-8G>T has been reported in the literature in heterozygous state in individuals affected with neonatal diabetes, congenital hyperinsulinism and adult type 2 diabetes (Proks_2006, Banerjee_2011, Carreira_2021), however, in the reported neonatal/congenital cases, unaffected parents were also noted to carry the variant (Proks_2006, Banerjee_2011). To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. Three clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar after 2014 without evidence for independent evaluation. Based on the evidence outlined above, the variant was classified as benign. -
not provided Uncertain:1Benign:1
Uncertain significance, criteria provided, single submitterclinical testingGeneDxOct 31, 2022Identified without a second variant in unrelated patients with congenital hyperinsulinism in published literature; however the variant was inherited from an unaffected parent in all cases (Proks et al., 2006; Banerjee et al., 2011); This variant is associated with the following publications: (PMID: 16613899, 33728157, 21378087) -
Likely benign, criteria provided, single submitterclinical testingCeGaT Center for Human Genetics TuebingenSep 01, 2022ABCC8: BS2 -
Hyperinsulinemic hypoglycemia, familial, 1 Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingIllumina Laboratory Services, IlluminaJan 12, 2018This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score, this variant could not be ruled out of causing disease and therefore its association with disease required further investigation. A literature search was performed for the gene, cDNA change, and amino acid change (if applicable). No publications were found based on this search. This variant was therefore classified as a variant of unknown significance for this disease. -
Diabetes mellitus, transient neonatal, 2 Benign:1
Benign, criteria provided, single submitterclinical testingIllumina Laboratory Services, IlluminaJan 12, 2018This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -
Permanent neonatal diabetes mellitus Benign:1
Likely benign, criteria provided, single submitterclinical testingIllumina Laboratory Services, IlluminaJan 12, 2018This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as likely benign is not then subjected to further curation. The score for this variant resulted in a classification of likely benign for this disease. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.22
Cadd
Benign
16
Dann
Benign
0.95

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs200091822; hg19: chr11-17498331; API